文献速递创伤与烧伤重症综合管理与镇静镇痛

一级创伤中心损伤控制性剖腹术使用率差异显著:实用随机最佳血小板与血浆比例研究结果

Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findings.
PubMed 文献 · J Trauma Acute Care Surg · 2017-01-01
一句话结论在12个北美一级创伤中心,损伤控制性剖腹术使用率33%–83%不等,但中心间死亡率无显著差异;作者认为减少损伤控制性剖腹术使用可能不降低死亡率,但可能减少相关并发症。

该研究基于实用随机最佳血小板与血浆比例试验,纳入12个北美一级创伤中心的急诊剖腹术患者,比较损伤控制性剖腹术与确定性手术管理的结局。329例急诊剖腹术中213例(65%)行损伤控制性剖腹术、116例(35%)行确定性手术管理,各中心损伤控制性剖腹术使用率为33%–83%(p=0.002)。损伤控制性剖腹术组中位损伤严重度评分为29(四分位距13–34),高于确定性手术管理组的21(四分位距22–41)(p<0.001)。损伤控制性剖腹术组24小时死亡率为19%对比确定性手术管理组4%(p<0.001),30天死亡率为28%对比19%(p<0.001)。混合效应模型中损伤控制性剖腹术与30天死亡率无显著关联(OR 2.33,95%CI 0.97–5.60),中心间死亡率无显著差异(p=0.63),损伤控制性剖腹术组脓毒症和呼吸机相关肺炎发生更频繁(p<0.05)。

要点

  • 12个北美一级创伤中心急诊剖腹术患者中损伤控制性剖腹术使用率为33%–83%(p=0.002),中心间差异显著。
  • 损伤控制性剖腹术组24小时死亡率为19%对比确定性手术管理组4%(p<0.001),30天死亡率为28%对比19%(p<0.001)。
  • 混合效应模型中损伤控制性剖腹术与30天死亡率无显著关联(OR 2.33,95%CI 0.97–5.60)。
  • 损伤控制性剖腹术组脓毒症和呼吸机相关肺炎发生更频繁(p<0.05)。
  • 80%(135/213)的损伤控制性剖腹术患者符合标准标准,作者认为减少损伤控制性剖腹术使用可能不降低死亡率,但可能减少相关并发症。

适用人群与场景

  • 12个北美一级创伤中心接受急诊剖腹术的创伤患者,随机分组基于实用随机最佳血小板与血浆比例试验的输血比例。

诊断标准与关键阈值

  • 标准损伤控制性剖腹术标准包括pH、国际标准化比值、温度和主要腹腔内血管损伤,但原文未给出具体界值。

研究设计与关键结果

  • 研究为基于实用随机最佳血小板与血浆比例试验的二次分析,纳入12个北美一级创伤中心329例急诊剖腹术患者,其中损伤控制性剖腹术213例(65%)、确定性手术管理116例(35%)。
  • 各中心损伤控制性剖腹术使用率为33%–83%(p=0.002)。
  • 损伤控制性剖腹术组中位损伤严重度评分为29(四分位距13–34),确定性手术管理组为21(四分位距22–41)(p<0.001)。
  • 损伤控制性剖腹术组24小时死亡率为19%,确定性手术管理组为4%(p<0.001);30天死亡率损伤控制性剖腹术组为28%,确定性手术管理组为19%(p<0.001)。
  • 混合效应模型中,损伤严重度评分(OR 1.05,95%CI 1.02–1.07)和主要腹腔内血管损伤(OR 2.7,95%CI 1.4–5.2)与损伤控制性剖腹术相关。
  • 损伤控制性剖腹术与30天死亡率无显著关联(OR 2.33,95%CI 0.97–5.60);30天死亡率的关联因素包括损伤严重度评分(OR 1.06,95%CI 1.02–1.09)、24小时内浓缩红细胞输注量(OR 1.10,95%CI 1.03–1.18)和年龄(OR 1.04,95%CI 1.01–1.06)。
  • 中心间死亡率无显著差异(p=0.63);损伤控制性剖腹术组脓毒症和呼吸机相关肺炎发生更频繁(p<0.05)。
  • 80%(135/213)的损伤控制性剖腹术患者符合标准标准。

证据类型、等级与局限

  • 证据类型:基于实用随机最佳血小板与血浆比例试验的治疗性研究,证据等级III级。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管各中心损伤控制性剖腹术使用率差异显著且中心间死亡率无显著差异,减少损伤控制性剖腹术使用可能不降低死亡率,但可能减少相关并发症。
  • 损伤控制性剖腹术组脓毒症和呼吸机相关肺炎发生更频繁(p<0.05)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Damage control laparotomy (DCL) is intended to limit deleterious effects from trauma-induced coagulopathy. DCL has been associated with mortality reduction, but may increase complications including sepsis, abscess, respiratory failure, hernia, and gastrointestinal fistula. We hypothesized that (1) DCL incidence would vary between institutions; (2) mortality rates would vary with DCL rates; (3) standard DCL criteria of pH, international normalized ratio, temperature and major intra-abdominal vascular injury would not adequately capture all patients.

METHODS: Trauma patients at 12 Level 1 North American trauma centers were randomized based on transfusion ratios as described in the Pragmatic, Randomized Optimal Platelet and Plasma Ratios trial. We analyzed outcomes after emergent laparotomy using a mixed-effects logistic model comparing DCL versus definitive surgical management with random effect for study site. Primary outcomes were 24-hour and 30-day mortality.

RESULTS: Three hundred twenty-nine patients underwent emergent laparotomy: 213 (65%) DCL and 116 (35%) definitive surgical management. DCL rates varied between institutions (33-83%), (p = 0.002). Median Injury Severity Score (ISS) was higher in the DCL group, 29 (interquartile range, 13-34) versus 21 (interquartile range, 22-41) (p < 0.001). Twenty-four-hour mortality was 19% with DCL versus 4% (p < 0.001); 30-day mortality was 28% with DCL versus 19% (p < 0.001). In a mixed-effects model, ISS and major intra-abdominal vascular injury were correlates of DCL (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.02-1.07 and OR, 2.7; 95% CI, 1.4-5.2). DCL was not associated with 30-day mortality (OR, 2.33; 95% CI, 0.97-5.60). Correlates included ISS (OR, 1.06; 95% CI, 1.02-1.09), PRBCs in 24 hours (OR, 1.10; 95% CI, 1.03-1.18), and age (OR, 1.04; 95% CI, 1.01-1.06). No significant mortality difference was detected between institutions (p = 0.63). Sepsis and VAP occurred more frequently with DCL (p < 0.05). Eighty percent (135/213) of DCL patients met standard criteria.

CONCLUSION: Although DCL utilization varied significantly between institutions, there was no significant mortality difference between centers. This finding suggests tempering DCL use may not decrease mortality, but could decrease related complications.

LEVEL OF EVIDENCE: Therapeutic study, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Watson JJ, Nielsen J, Hart K, et al. Damage control laparotomy utilization rates are highly variable among Level I trauma centers: Pragmatic, Randomized Optimal Platelet and Plasma Ratios findings. J Trauma Acute Care Surg. 2017. PMID: 28225739. doi:10.1097/TA.0000000000001357

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。